Abstract:ABSTRACT Mammalian target of rapamycin (mTOR) is a key regulator of metabolism in the mammalian cell. Here, we show the essential role for mTOR signaling in the immune response to bacterial infection. Inhibition of mTOR during infection with Staphylococcus aureus revealed that mTOR signaling is required for bactericidal free radical production by phagocytes. Mechanistically, mTOR supported glucose transporter GLUT1 expression, potentially through hypoxia-inducible factor 1α, upon phagocyte activation. Cytokine and chemokine signaling, inducible nitric oxide synthase, and p65 nuclear translocation were present at similar levels during mTOR suppression, suggesting an NF-κB-independent role for mTOR signaling in the immune response during bacterial infection. We propose that mTOR signaling primarily mediates the metabolic requirements necessary for phagocyte bactericidal free radical production. This study has important implications for the metabolic requirements of innate immune cells during bacterial infection as well as the clinical use of mTOR inhibitors. IMPORTANCE Sirolimus, everolimus, temsirolimus, and similar are a class of pharmaceutics commonly used in the clinical treatment of cancer and the anti-rejection of transplanted organs. Each of these agents suppresses the activity of the mammalian target of rapamycin (mTOR), a master regulator of metabolism in human cells. Activation of mTOR is also involved in the immune response to bacterial infection, and treatments that inhibit mTOR are associated with increased susceptibility to bacterial infections in the skin and soft tissue. Infections caused by Staphylococcus aureus are among the most common and severe. Our study shows that this susceptibility to S. aureus infection during mTOR suppression is due to an impaired function of phagocytic immune cells responsible for controlling bacterial infections. Specifically, we observed that mTOR activity is required for phagocytes to produce antimicrobial free radicals. These results have important implications for immune responses during clinical treatments and in disease states where mTOR is suppressed.

Mtorc1-Activated Monocytes Increase Tregs and Inhibit the Immune Response to Bacterial Infections.

mTOR is critical for intestinal T-cell homeostasis and resistance to Citrobacter rodentium

mTOR signaling is required for phagocyte free radical production, GLUT1 expression, and control of Staphylococcus aureus infection

Repression of Mammalian Target of Rapamycin Complex 1 Inhibits Intestinal Regeneration in Acute Inflammatory Bowel Disease Models.

MTOR Involved in Bacterial Elimination Against Trueperella Pyogenes Infection Based on Mice Model by Transcriptome and Biochemical Analysis.

Role of Tumor Suppressor TSC1 in Regulating Antigen-Specific Primary and Memory CD8 T Cell Responses to Bacterial Infection

Mtorc1 Regulates Flagellin-Induced Inflammatory Response in Macrophages

The Role of TSC1 in the Macrophages Against Vibrio vulnificus Infection

Mtorc1 Inhibits NF-κB/NFATc1 Signaling and Prevents Osteoclast Precursor Differentiation, in Vitro and in Mice

Thrombospondin 1 Modulates Monocyte Properties to Suppress Intestinal Mucosal Inflammation

Tumor Microenvironment Modulates Immunological Outcomes of Myeloid Cells with mTORC1 Disruption

TSC 1 Regulates the Balance Between Effector and Regulatory T Cells

mTORC1 signaling is crucial for regulatory T cells to suppress macrophage-mediated inflammatory response after acute myocardial infarction

TSC1 Suppresses Macrophage Necroptosis for the Control of Infection by Fungal Pathogen Candida Albicans

TSC1 controls macrophage polarization to prevent inflammatory disease

Modulation of TSC-mTOR Signaling on Immune Cells in Immunity and Autoimmunity.

mTOR Deletion Alleviates CD4+ T-Cell Dysfunction in Sepsis through Reducing CTLA4 Accumulation Mediated by Rescuing Autophagy

Mtorc1 Mediates Peptidoglycan Induced Inflammatory Cytokines Expression and NF-κB Activation in Macrophages

Myeloid-specific Rictor deletion induces M1 macrophage polarization and potentiates in vivo pro-inflammatory response to lipopolysaccharide

Lack of mTORC2 signalling in CD11c+ myeloid cells inhibits their migration and ameliorates experimental colitis

Macrophage-Induced Tumor Angiogenesis is Regulated by the Tsc2-Mtor Pathway.